Core Viewpoint - Select Medical Holdings Corp. is experiencing significant market activity, with shares rising due to a planned acquisition that will take the company private for $3.9 billion [1][2]. Group 1: Acquisition Details - Select Medical has entered into a definitive agreement for a consortium led by Executive Chairman Robert Ortenzio and Senior Executive Vice President Martin Jackson to acquire all outstanding shares at a price of $16.50 each [2]. - The merger agreement received unanimous approval from the disinterested members of the company's board of directors [2]. - The transaction is expected to close in the middle of the year, pending shareholder approval and other closing conditions [3]. Group 2: Financial Performance - The company reported a net income attributable to shareholders of $20.17 million, a turnaround from a net loss of $16.05 million in 2024 [4]. - Total revenues increased by 7.7 percent year-on-year, reaching $1.4 billion, up from $1.3 billion [4]. - Select Medical is set to distribute dividends of $0.0625 per share to shareholders on record as of March 2, 2026, payable on March 12 [3].
Select Medical (SEM) Soars 8.4%, Traders Snap up Shares Ahead of Delisting